• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
ZHANG Su-yang, HE Dong-dong, WANG Li, LIU Dan, QIU Hong-xia. Evaluation of the efficacy of autologous hematopoietic stem cell transplantation combined with intermittent low dose cyclophosphamide in the treatment of severe lupus nephritis[J]. Journal of Clinical Nephrology, 2019, 19(11): 838-842. DOI: 10.3969/j.issn.1671-2390.2019.11.010
Citation: ZHANG Su-yang, HE Dong-dong, WANG Li, LIU Dan, QIU Hong-xia. Evaluation of the efficacy of autologous hematopoietic stem cell transplantation combined with intermittent low dose cyclophosphamide in the treatment of severe lupus nephritis[J]. Journal of Clinical Nephrology, 2019, 19(11): 838-842. DOI: 10.3969/j.issn.1671-2390.2019.11.010
shu

Evaluation of the efficacy of autologous hematopoietic stem cell transplantation combined with intermittent low dose cyclophosphamide in the treatment of severe lupus nephritis

  • Department of Rheumatology, Xi'an City Fifth Hospital, Xi'an 710082, China

More Information
  • Received Date: March 24, 2019
  • Available Online: May 11, 2023
  • Published Date: November 27, 2019
    Graphical Abstract
    • Abstract
  • Objective To evaluate the efficacy of autologous hemopoietic stem cell transplantation(ASCT) combined with intermittent low-dose cyclophosphamide in the treatment of severe lupus nephritis and its effect on serum anti-dsDNA antibody, PBMC protein carbonyl concentration and Fas expression rate. Methods 120 patients with severe lupus nephritis admitted to the Fifth Hospital of Xi'an from January 2016 to January 2018 were randomly divided into observation group and control group; the control group was treated with ASCT method, and the observation group was treated with ASCT method combined with intermittent small dose. Cyclophosphamide treatment; systemic lupus erythematosus disease activity index(SLEDAI) was collected before treatment and 6 months after treatment, and the number of erythrocytes, urine protein and albumin in urine were detected in the two groups, platelets, anti-U1 ribonucleoprotein(U1RNP) antibody, complement C3, peripheral blood CD4+T, CD8+T, CD4+/CD8+ ratio, regulatory T cell(Treg), and CD20+ B cell percentage, dsDNA antibody, PBMC protein carbonyl concentration, T cell Fas expression rate, B cell Fas expression rate and T, B lymphocyte apoptosis rate. Results After treatment, the SLEDAI score of the observation group was significantly lower than that of the control group(P<0.05), the number of urinary red blood cells, urine protein level, serum dsDNA antibody, serum PBMC protein carbonyl concentration, Fas expression rate of T cells and B cells, T cells and The apoptosis rate of B cells was significantly lower than that of the control group(P<0.05). The levels of serum albumin, platelet, C3, CD4+, CD8+, CD4+/CD8+, Treg and CD20+ B cells in the observation group were significantly higher than those in the control group(P<0.05).The positive rate of U1RNP in the observation group was significantly lower than that in the control group(P<0.05). Conclusions The use of ASCT combined with intermittent low-dose cyclophosphamide in the treatment of severe lupus nephritis can effectively improve the clinical efficacy, and reduce serum anti-dsDNA antibody, PBMC protein carbonyl concentration level and Fas expression rate.
    • FullText(HTML)
    • References (15)
  • [1]
    Poulsen NN, Pedersen ME, Østergaard J, et al. Flow-induced dispersion analysis for probing anti-dsDNA antibody binding heterogeneity in systemic lupus erythematosus patients:toward a new approach for diagnosis and patient stratification[J]. Anal Chem, 2016, 88(18):9056-9061.
    [2]
    Nakano M, Takahashi Y, Yamashita H, et al. SAT0313 Different serological profiles and activities in two onset categories of lupus nephritis[J]. Ann Rheum Dis, 2016, 75(Suppl 2):780-781.
    [3]
    Khan AR, Farid TA, Pathan A, et al. Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy:A systematic review and meta-analysis[J]. Circ Res, 2016, 118(6):984-993.
    [4]
    朱晓叶. 环磷酰胺药物基因多态性与狼疮性肾炎疗效和不良反应的相关性研究[D]. 复旦大学, 2012.
    [5]
    Zhao J, Bai W, Zhu P, et al. Chinese SLE Treatment and Research group (CSTAR) registry VII:prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus[J]. Lupus, 2016, 25(6):652-657.
    [6]
    Liu Y, Zhan Z, Cai J, et al. Projected iterative soft-thresholding algorithm for tight frames in compressed sensing magnetic resonance imaging[J]. IEEE Trans Med Imaging, 2016, 35(9):2130-2140.
    [7]
    唐代荣, 廖湘平, 李志湘, 等. 铁调素和狼疮性肾炎的相关性研究进展[J]. 当代临床医刊, 2017, 30(1):2881-2883, 2892.
    [8]
    Jia XF, Kowalski RG, Sciubba DM, et al. Critical care of traumatic spinal cord injury[J]. J Intensive Care Med, 2013, 28(1):12-23.
    [9]
    Feige U, Krivelevich M, Reichman D. Contagious sets in random graphs[J]. Ann Appl Probab, 2017, 27(5):2675-2697.
    [10]
    Moreau F, Thévenon E, Blanvillain R, et al. The Myb-domain protein ultrapetala1 interacting factor 1 controls floral meristem activities in arabidopsis[J]. Development, 2016, 143(7):1108-1119.
    [11]
    古鉴. 调节性T细胞功能稳定性及其在免疫治疗中的作用机制研究[D]. 南京医科大学, 2016.
    [12]
    Adachi T, Oki M, Saka H. Management considerations for the treatment of idiopathic massive hemoptysis with endobronchial occlusion combined with bronchial artery embolization[J]. Intern Med, 2016, 55(2):173-177.
    [13]
    刘雷, 李良志, 胡婉梅, 等. 不同血液净化方式联合免疫抑制剂对重症狼疮肾炎的治疗观察[J]. 临床肾脏病杂志, 2017, 17(2):110-114.
    [14]
    Lehtimäki K, Möttönen T, Järventausta K, et al. Outcome based definition of the anterior thalamic deep brain stimulation target in refractory epilepsy[J]. Brain Stimul, 2016, 9(2):268-275.
    [15]
    Lithgow T. The assembly of beta-barrel proteins into bacterial outer membranes[J]. Biophys J, 2017, 112(3):329a.
    • Related Articles

  • Related Articles

    [1]Wang Jing, Li Bin. Clinical value of antineutrophil cytoplasmic antibody positive expression in children with lupus nephritis[J]. Journal of Clinical Nephrology, 2024, 24(11): 881-886. DOI: 10.3969/j.issn.1671-2390.2024.11.001
    [2]Yang Ming, Fang Ye-hua. Expression and clinical significance of X-box binding protein 1 in peripheral blood B cells of patients with lupus nephritis[J]. Journal of Clinical Nephrology, 2024, 24(3): 209-215. DOI: 10.3969/j.issn.1671-2390.2024.03.005
    [3]Wan Jing-fang, Lin Jing, Zhang Wei-wei, Xiang Yang, Chen Ke-hong. Impact of blood flow rate on mortality in hemodialysis patients[J]. Journal of Clinical Nephrology, 2023, 23(3): 185-190. DOI: 10.3969/j.issn.1671-2390.2023.03.002
    [4]Chen Xuan. Expression and clinical significance of miR-16-5p and IFITM3 in peripheral blood mononuclear cells of patient with sepsis-associated acute kidney injury[J]. Journal of Clinical Nephrology, 2023, 23(1): 45-51. DOI: 10.3969/j.issn.1671-2390.2023.01.008
    [5]Zhou Ji, Shen Li-min. Relationship between serum osteopontin concentration and progression of diabetic nephropathy and renal function[J]. Journal of Clinical Nephrology, 2022, 22(8): 653-658. DOI: 10.3969/j.issn.1671-2390.2022.08.006
    [6]Yang Min, Xu Si, Wu Sha, Li Xiao-ning. Predictive value of glomerular filtration rate estimated by three FAS formulas for all-cause mortality in patients in coronary care unit[J]. Journal of Clinical Nephrology, 2021, 21(7): 535-539. DOI: 10.3969/j.issn.1671-2390.l20-190
    [7]LI Zhang-hong, ZHANG Rui-rui, LUO Qiu-ju. Autophagy in patients with lupus nephritis and its effect on podocyte related protein expression[J]. Journal of Clinical Nephrology, 2020, 20(5): 385-389. DOI: 10.3969/j.issn.1671-2390.2020.05.007
    [8]FU Shuai, LI Xiao-ning. The research development of formulas for calculating glomerular filtration rate: from Cockcroft-Gault formula to full age spectrum (FAS)formula[J]. Journal of Clinical Nephrology, 2020, 20(1): 73-77. DOI: 10.3969/j.issn.1671-2390.2020.01.014
    [9]WANG Guo-ping, WANG Jian-feng, CAI Guo-jun, WU-Jia-feng. Effect of transforming growth factor-β (TGF-β) on gene expression profile of human tubular epithelial cells and bioinformatic analysis[J]. Journal of Clinical Nephrology, 2019, 19(6): 447-452. DOI: 10.3969/j.issn.1671-2390.2019.06.013
    [10]LUO Min-hong, YANG Tie-cheng, ZHU Lang-jing, CHEN Zhen-wei, ZENG Hai-ou, MO Cai-ju, WU Qiang, XIAO Jie. Effects of Anti-GPIbα antibody on the expression of platelet GPIbα, CD62P and CD63 in maintenance hemodialysis patients[J]. Journal of Clinical Nephrology, 2018, 18(12): 737-742. DOI: 10.3969/j.issn.1671-2390.2018.12.004

Catalog

    Get Citation
    PDF
    XML
    Article views (331) PDF downloads (425) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles
    Links

    Website Copyright © Wuhan Medical and Health Association Joint Office Editorial Department of Journal of Clinical Nephrology   备案号：鄂ICP备13011742号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return